Title of the centre:
WHO Collaborating Centre for Clinical Laboratory Standards and Accreditation
Director / Head:
Clinical and Laboratory Standards Institute
950 West Valley Road, Suite 2500, PA 19087-1898
(1-610) 688 0100
(1-610) 688 0700
Date of Designation:
Terms of Reference:
- By working with the regional PAHO office, CAREC, and other key organizations, continually assess the clinical laboratory needs in the Region of the Americas, and implement a plan to address the needs;
- Develop new and update existing standards and guidelines targeted to the identified needs on a global basis
- Increase access to CLSI products and services (e.g., through translations, document simplification, regional pricing structure, organizational partnerships) to improve clinical laboratory performance;
- Serve as a leader in standardization of terminology and strive to harmonize terms and procedures on a global basis;
- Provide distance-based learning modalities and direct technical assistance (on topics such as laboratory techniques,quality systems management) as identified;
- Maintain a current index of all the information on CLSI products and to make it available to interested countries to serve as a reference for improving laboratory quality;
- Provide resource information and appropriate mechanisms to increase use of standards and guidelines in clinical laboratories globally.
- Develop mutually agreeable work plans for implementing these terms of reference.
- Health Technology (including laboratory services; but excluding blood safety)
- Safety measures in microbiology
- Research policy & development
Types of activity:
- Collection; collation and dissemination of information
- Product development (guidelines; manual; methodologies; etc.)
- Providing technical advise to WHO
WHO organization wide expected result:
1.6 - Support provided to Member States in order to achieve the minimum core capacities required by the International Health Regulations (2005) for the establishment and strengthening of alert and response systems for use in epidemics and other public health emergencies of international concern.
11.1 - Formulation and monitoring of comprehensive national policies on access, quality and use of essential medical products and technologies advocated and supported.
11.3 - Evidence based policy guidance on promoting scientifically sound and cost-effective use of medical products and technologies by health workers and consumers developed and supported within the Secretariat and regional and national programmes.
VERCAUTEREN Gaby Henriette
+41 22 79 14728
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork